Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05169944
Title Magrolimab in Children and Adults With Recurrent or Progressive Malignant Brain Tumors (PNOC025)
Acronym PNOC025
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of California, San Francisco
Indications
Therapies
Age Groups: child | adult | senior
Covered Countries USA


No variant requirements are available.